Published in Cancer Weekly, September 11th, 2001
"Pediatric patients with solid tumors treated with prolonged dose-intensive chemoradiotherapy are poor mobilizers of peripheral blood stem cells (PBSC)," explained Dr. Mitchell S. Cairo at Columbia University and colleagues at the North Texas Hospital for Children (Dallas), Georgetown University's Lombardi Cancer Center (Washington, D.C.), the Children's Hospital of Orange County, California, and the National Institutes of Health in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.